Do we need anti-obesity drugs?

Do we need anti-obesity drugs?

Item
http://www.wikidata.org/entity/Q38071006
Lipoprotein subfractions in metabolic syndrome and obesity: clinical significance and therapeutic approachesNext generation of weight management medications: implications for diabetes and CVD riskNew advances in models and strategies for developing anti-obesity drugs.PPARγ neddylation essential for adipogenesis is a potential target for treating obesity.Piloting a new approach to the treatment of obesity using dexamphetamine.The relationship between BMI and the prescription of anti-obesity medication according to social factors: a population cross sectional study.New pharmacological treatments for the management of obesity.Tolerability and safety of the new anti-obesity medications.Endospanin 1 silencing in the hypothalamic arcuate nucleus contributes to sustained weight loss of high fat diet obese mice.TNP [N2-(m-Trifluorobenzyl), N6-(p-nitrobenzyl)purine] ameliorates diet induced obesity and insulin resistance via inhibition of the IP6K1 pathway.Dietary polyphenols against metabolic disorders: How far have we progressed in the understanding of the molecular mechanisms of action of these compounds?Improving long-term weight loss maintenance: can we do it?
P2860

Do we need anti-obesity drugs?

Item
http://www.wikidata.org/entity/Q38071006
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Do we need anti-obesity drugs?
@en
type
label
Do we need anti-obesity drugs?
@en
prefLabel
Do we need anti-obesity drugs?
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P478
P577
P5875
P698
P921
P356
P1433
P1476
Do we need anti-obesity drugs?
@en
P2093
P2860
P304
P31
P356
P478
P577
P5875
P698
P921